LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global pre-packed chromatography columns market to grow at a CAGR of more than 8% during the forecast period, according to their latest report.
The research study covers the present scenario and growth prospects of the global pre-packed chromatography columns market for 2016-2020. The report also lists pharmaceutical and biotechnology, food and beverages, water and environment, and others (cosmetics, diagnostics, genetic engineering, and academic research) as the four major end-user segments.
Request a sample report: http://www.technavio.com/request-a-sample?report=52233
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Technavio analysts highlight the following four factors that are contributing to the growth of the global pre-packed chromatography columns market:
- Wide range of end-users
- Increased demand in pharmaceutical industry
- Rise in strategic initiatives by vendors
- Increase in number of diagnostic centers
Wide range of end-users
Pre-packed chromatography columns find their application in various areas, including purification of proteins, biologic drug development for resin screening, sample preparation, protein purification, anion and cation exchange, desalting, and polishing.
A growing number of monoclonal antibodies (mAbs) are used in the development phase and clinical trials of drugs among end-users. These processes use chromatography, thereby driving the demand for columns. “With intense competition prevailing in the market, vendors are focusing on providing a wide variety of customized solutions with high reliability and reproducibility for different applications, which suit the varying needs of end-users,” says Amber Chourasia, a lead analyst at Technavio for lab equipment research.
Increased demand in pharmaceutical industry
An increase in the aging population worldwide has led to a rapid growth in the patient population suffering from a broad range of diseases. The aging population in the US will double and reach a total of 71 million by 2030. There is a significant rise in the prevalence of old age-related diseases, including cardiovascular diseases (CVDs), Alzheimer's disease, and cancer.
A growing number of pharmaceutical companies worldwide are using chromatography for developing a wide variety of drugs indicated for various diseases and medical conditions. The use of chromatography columns has significantly increased in the biopharmaceutical industry as the purification of biopharmaceuticals is considered a major bottleneck during the manufacturing process.
The increased spending on medicines has also increased the market potential of the pharmaceutical industry, allowing new players to venture into the market to develop new drugs, which in turn will require chromatography columns for various purposes.
Rise in strategic initiatives by vendors
There has been an increase in the number of strategic initiatives by vendors in the pre-packed chromatography columns market. These initiatives aim to leverage each other’s USPs, resulting in many partnerships between companies worldwide. The companies take advantage of each other's customer base, technology, financial capability, and R&D capabilities to increase their market shares and establish their presence in the chromatography market. For instance, in February 2014, Thermo Fisher Scientific acquired Life Technologies, The USD 13.6 billion acquisition was aimed at strengthening Thermo Fisher Scientific’s presence in the life sciences, research, specialty diagnostics, and applied markets.
Therefore, strategic initiatives help companies expand their product portfolios and venture into untapped markets, especially in the developing countries, by launching products with the help of the local players’ market presence. These factors will significantly impact the demand for chromatography products in different regions.
Increase in number of diagnostic centers
Ever-changing consumer demand has resulted in shifting diagnostic testing from hospitals and commercial laboratories closer to home, which has lowered the cost of testing. Pre-packed chromatography testing has gained extensive popularity in research laboratories and hospitals for diagnostic purposes, apart from its use in biochemical and pharmaceutical areas for drug discovery and development.
Diagnostic centers employ different chromatographic platforms as diagnostic tools to carry out metabolic profiling for identification of diseases. Chromatography is vastly applied in cancer, which is a major cause of death worldwide. It metabolically profiles the disease cells and subsequently assists in the identification of cancer biomarkers crucial in the treatment process.
During the forecast period, improved diagnostics tools, accurate treatment monitoring, faster response times, increased availability of over-the-counter tests, and easy availability of chromatography columns at low costs will lead to an increase in the number of diagnostic centers worldwide. “This development will be more prominent in the rural areas where people tend to postpone the diagnosis and treatment of various chronic diseases, including cancers and CVDs, due to difficulty in arranging for transport, lack of accessible healthcare facilities. Thus, there is significant growth opportunity for the manufacturers of pre-packed chromatography columns,” says Amber.
Browse Related Reports:
- Global Gas Chromatograph Market 2016-2020
- Global Hemoglobin Testing Market 2016-2020
- Global Water Bath Market 2016-2020
Do you need a report on a market in a specific geographical cluster or country but can’t find what you’re looking for? Don’t worry, Technavio also takes client requests. Please contact email@example.com with your requirements and our analysts will be happy to create a customized report just for you.
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.
If you are interested in more information, please contact our media team at firstname.lastname@example.org.